Shanghai Desano Pharmaceutical Group Co., Ltd.-preview

Desano

Shanghai Desano Pharmaceutical Group Co., Ltd.

Private

ShanghaiHealthcare & Life Scienceshttps://www.desano.com

Last Round

VC Round

Feb 2, 2023

Company Overview

Shanghai Desano Pharmaceutical Group Co., Ltd. is a pharmaceutical company that engages in the research and development, manufacturing, and sales of high-quality pharmaceutical drugs, with a focus on treatments for HIV and malaria.

Sector

Healthcare & Life Sciences

Verticals

Pharma Supply Chain, Biotechnology, Drug Discovery

Business Model

B2B

Customer Profile

Government Contracts, Services & Consulting

AI Layer

Non-AI

Keywords

Active Pharmaceutical IngredientsAPIanti-retroviral drugsARV drugsgeneric drugsanti-malarial drugsContract Development and Manufacturing OrganizationCDMOFinished Pharmaceutical ProductsFPPpharmaceutical manufacturingHIV treatmentChinese API supplierFinished Dosage FormulationsFDFpharmaceutical intermediatesContract Manufacturing OrganizationCMOEfavirenzTenofovir

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Shanghai Desano Pharmaceutical Group Co., Ltd. Comps

Public and private peers based on sector, stage, and business model.

Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Shanghai Desano Pharmaceutical Group Co., Ltd. Funding Rounds

Historical fundraising activity

Round	Date	Amount Raised	Valuation	Investors	Sources
VC Round	Feb 2, 2023
Series A Extension	Mar 14, 2022

View all Funding Rounds

Key People

Founding team and executive leadership

PROSENJIT BOSE

Chief Operating Officer

Executive Team

Shanghai Desano Pharmaceutical Group Co., Ltd. Investors

Notable investors and investment history

Investor	Rounds
Lingang Blue Bay Capital	Series A Extension
PICC Capital Insurance Asset Management	VC Round
Zhenxiang Capital	VC Round
Mingjia Capital	VC Round
Shenzhen Capital Group	Series A Extension

View all Investors

Shanghai Desano Pharmaceutical Group Co., Ltd. Filings

SEC and related filings with document metadata.

Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Shanghai Desano Pharmaceutical Group Co., Ltd. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Shanghai Desano Pharmaceutical Group Co., Ltd.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersShanghai

Employee Range134

Year Founded2000

Last FundingFeb 2, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.